Design and Challenges of the Randomized Evaluation of Normal versus Augmented Level Replacement Therapy (RENAL) Trial: High-Dose versus Standard-Dose Hemofiltration in Acute Renal Failure
Author(s) -
Sunny Eloot,
Wim Van Biesen,
Annemieke Dhondt,
E. Billiet,
Pascal Verdonck,
Raymond Vanholder,
Martin Válek,
František Lopot,
S Sulková,
Vladimír Polakovič,
R. T. Noel Gibney,
Sean M. Bagshaw,
Demetrios J. Kutsogiannis,
C. Johnston,
Maria Alquist,
Juan P. Bosch,
Na Jiang,
Jiaqi Qian,
Aiwu Lin,
Bengt Lindholm,
Jonas Axelsson,
Qiang Yao,
Jongha Park,
Hyun Chul Chung,
JongSoo Lee,
Byeong Man Lee,
DongMin Kim,
Jae Cheol Hwang,
MinWoo Jo,
Maengseok Noh,
Jung Woo Shin,
Jihong Yang,
Li-Tao Cheng,
Yue Gu,
Lijun Tang,
Tao Wang,
M. Lindholm,
H.F. Woods,
Chen Cheng,
Po Sung Lim
Publication year - 2008
Publication title -
blood purification
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 57
eISSN - 1421-9735
pISSN - 0253-5068
DOI - 10.1159/000148400
Subject(s) - renal replacement therapy , medicine , hemofiltration , randomized controlled trial , clinical trial , intensive care medicine , intensive care , acute kidney injury , sample size determination , hemodialysis , surgery , statistics , mathematics
The optimal dose of renal replacement therapy (RRT) in acute renal failure (ARF) is uncertain.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom